.
Having a closer look at the study, it turns out that "100% cure rate at 6 days" was only 6 patients. Still impressive, and it screams, "do a bigger study NOW!", but along with methodological flaws in the study due to its (understandable) hastiness, it's not as conclusive as it appeared at first glance.
Still, it might be the "real deal". Every person it's been tried on was virus-free within 6 days, and most within 5 days actually. Even though it's only 6 people, it's a rather startling result and very promising.
Must wait and see. The nice thing is, with only a 6-day duration, large-scale studies can be run quickly, in less than a week, plus setup time and data analysis time.
If it ends up being the "real deal" and enters widespread use, the really cool thing is that the azithromycin will not only work along with the anti-malarial drug to cure, but it will also simultaneously prevent secondary bacterial respiratory infections as a bonus. Curing while protecting from some kinds of complications, a real "one-two punch".
.
Pudding Mittens wrote: